Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 33, 2019 - Issue 4
293
Views
23
CrossRef citations to date
0
Altmetric
Research Articles

Precise discovery of a STAT3 inhibitor from Eupatorium lindleyanum and evaluation of its activity of anti-triple-negative breast cancer

, , , , , & show all
Pages 477-485 | Received 22 Jun 2017, Accepted 18 Oct 2017, Published online: 31 Oct 2017

References

  • Banerjee K, Resat H. 2016a. Constitutive activation of STAT3 in breast cancer cells: A review. Int J Cancer. 138:2570–2578.10.1002/ijc.v138.11
  • Cáceres A, Menéndez H, Méndez E, Cohobón E, Samayoa BE, Jauregui E, Peralta E, Carrillo G. 1995. Antigonorrhoeal activity of plants used in Guatemala for the treatment of sexually transmitted diseases. J Ethnopharmacol. 48:85–88.10.1016/0378-8741(95)01288-O
  • Chinese Materia Medica (Zhonghua Bencao). 1998. Shanghai: Shanghai Science & Technology Press; Vol. 7, p. 839.
  • Chun J, Li RJ, Cheng MS, Kim YS. 2015a. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells. Cancer Lett. 357:393–403.10.1016/j.canlet.2014.11.049
  • Federica T, Anselmo P, Eleonora Z, Luigi R, Davide C, Marina M, Patrizia V, Luigi F, Silverio T. 2015b. Triple-negative breast cancer: new perspectives for targeted therapies. OncoTargets Thera. 8:177–193.
  • Habtemariam S. 2001. Antiinflammatory activity of the antirheumatic herbal drug, gravel root (Eupatorium purpureum): further biological activities and constituents. Phytother Res. 15:687–690.10.1002/(ISSN)1099-1573
  • Hernández LR, Catalán CAN, Cerda-Garcia-Rojas CM, Joseph-Nathan P. 1994a. Phytochemistry. 37:1331–1335.10.1016/S0031-9422(00)90408-4
  • Huo J, Yang SP, Ding J, Yue JM. 2004. Cytotoxic sesquiterpene lactones from Eupatorium lindleyanum. J Nat Prod. 67:1470–1475.10.1021/np040023 h
  • Liu B, Cao L, Zhang L, Yuan X, Zhao B. 2017b Feb. Hepatotoxicity of Eupatorium adenophorum extracts and the identification of major hepatotoxic components. Nat Prod Res. 20:1–5.
  • Poli V, Camporeale A. 2015c. STAT3-mediated metabolic reprograming in cellular transformation and implications for drug resistance. Front Oncol. 5:121–141.
  • Schust J, Sperl B, Hollis A, Mayer TU, Berg T. 2006. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol. 13:1235–1242.10.1016/j.chembiol.2006.09.018
  • Shen YC, Lo KL, Kuo YH, Khalil AT. 2005b. Cytotoxic sesquiterpene lactones from Eupatorium kiirunense, a coastal plant of Taiwan. J Nat Prod. 68:745–750.10.1021/np040214 k
  • Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D, Sebti SM. 2005a. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene. 24:3236–3245.10.1038/sj.onc.1208470
  • Wang Y, Ma X, Yan S, Shen S, Zhu H, Gu Y, Wang H, Qin G, Yu Q. 2009. 17-Hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus Kinases and induces apoptosis of human cancer cells. Cancer Res. 69:7302–7310.10.1158/0008-5472.CAN-09-0462
  • Wu SQ, Xu NY, Sun Q, Han HY, Zhang J. 2012. Six new sesquiterpenes from Eupatorium lindleyanum. Helvetica Chim Acta. 95:1637–1644.10.1002/hlca.v95.9
  • Xu R, Weng J, Hu L, Peng G, Ren Z, Deng J, Jia Y, Wang C, He H, Hu Y. 2017a Sep. Anti-NDV activity of 9-oxo10,11-dehydroageraphorone extracted from Eupatorium adenophorum Spreng in vitro. Nat Prod Res. 7:1–4.
  • Yang NY, Qian SH, Duan JA, Li P, Tian LJ. 2007. Cytotoxic sesquiterpene lactones from Eupatorium lindleyanum. J Asian Nat Prod Res. 9:339–345.10.1080/10286020600727673
  • Yang B, Zhao YP, Lou CH, Zhao HJ. 2016b. Eupalinolide O, a novel sesquiterpene lactone from Eupatorium lindleyanum DC., induces cell cycle arrest and apoptosis in human MDA-MB-468 breast cancer cells. Oncol Rep.. 36:2807–2813.10.3892/or.2016.5115
  • Youssef D, Frahm AW. 1994b. Constituents of the Egyptian Centaurea scoparia; Chlorinated Guaianolides of the aerial parts. Planta Med. 60:267–271.10.1055/s-2006-959473
  • Zhang X, Blaskovich MA, Forinash KD, Sebti SM. 2014. Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours. Br J Cancer. 111:894–902.10.1038/bjc.2014.349

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.